Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hepatitis B 1Fatigue 1Carcinoma, Hepatocellular 1

Interventions

Psychiatric Rehabilitation 2Methods 2Early Intervention, Educational 2Counseling 2Bupropion 2tanespimycin 1ruxolitinib 1rucaparib 1pembrolizumab 1motexafin gadolinium 1ixabepilone 1abiraterone 1Zinc Oxide 1Varenicline 1Urinalysis 1Uncertainty 1Tobacco Use Cessation Devices 1Tissue Banks 1Tinzaparin 1Surveys and Questionnaires 1Psychosocial Intervention 1Psychology, Positive 1Polymerase Chain Reaction 1Palliative Care 1Paclitaxel 1Observation 1Nicotine Replacement Therapy 1Nicotine 1Interleukin-15 1INCB057643 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Urinalysis × Gastrointestinal × Clear all
NCT00580281 2013-10-24

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Completed
33 enrolled
GastrointestinalMyeloidOther hematologic neoplasm

Leukemia, Stomach Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡